Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 171,970Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9NOVARTIS

02 2SANDOZ

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ZOLEDRONIC ACID

US Patent Number : 8324189

Drug Substance Claim :

Drug Product Claim :

Application Number : 21223

Patent Use Code : U-1308

Delist Requested :

Patent Use Description : MULTIPLE MYELOMA

Patent Expiration Date : 2025-05-29

blank

02

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ZOLEDRONIC ACID

US Patent Number : 8324189

Drug Substance Claim :

Drug Product Claim :

Application Number : 21223

Patent Use Code : U-1308

Delist Requested :

Patent Use Description : MULTIPLE MYELOMA

Patent Expiration Date : 2025-05-29

blank

03

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ZOLEDRONIC ACID

US Patent Number : 8324189

Drug Substance Claim :

Drug Product Claim :

Application Number : 21223

Patent Use Code : U-1309

Delist Requested :

Patent Use Description : BONE METASTASES

Patent Expiration Date : 2025-05-29

blank

04

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ZOLEDRONIC ACID

US Patent Number : 8324189

Drug Substance Claim :

Drug Product Claim :

Application Number : 21223

Patent Use Code : U-1309

Delist Requested :

Patent Use Description : BONE METASTASES

Patent Expiration Date : 2025-05-29

blank

05

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ZOLEDRONIC ACID

US Patent Number : 8324189

Drug Substance Claim :

Drug Product Claim :

Application Number : 21223

Patent Use Code : U-53

Delist Requested :

Patent Use Description : HYPERCALCEMIA OF MALIG...

Patent Expiration Date : 2025-05-29

blank

06

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ZOLEDRONIC ACID

US Patent Number : 8324189

Drug Substance Claim :

Drug Product Claim :

Application Number : 21223

Patent Use Code : U-53

Delist Requested :

Patent Use Description : HYPERCALCEMIA OF MALIG...

Patent Expiration Date : 2025-05-29

blank

07

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ZOLEDRONIC ACID

US Patent Number : 7932241

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21223

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-02-05

blank

08

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ZOLEDRONIC ACID

US Patent Number : 8324189*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 21223

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-11-29

blank

09

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ZOLEDRONIC ACID

US Patent Number : 8324189*PED

Drug Substance Claim :

Drug Product Claim :

Application Number : 21223

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-11-29

blank

10

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

ZOLEDRONIC ACID

US Patent Number : 7932241

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21817

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-02-05

blank